Prot#NLY01-PD-1: Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of 36 Weeks of Treatment with NLY01 in Early-stage Parkinson’s Disease
- Simuni, Tatyana (PD/PI)
Project: Research project